BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23685085)

  • 1. 3M Cavilon No-Sting Barrier Film or topical corticosteroid (mometasone furoate) for protection against radiation dermatitis: A clinical trial.
    Shaw SZ; Nien HH; Wu CJ; Lui LT; Su JF; Lang CH
    J Formos Med Assoc; 2015 May; 114(5):407-14. PubMed ID: 23685085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, paired comparison of No-Sting Barrier Film versus sorbolene cream (10% glycerine) skin care during postmastectomy irradiation.
    Graham P; Browne L; Capp A; Fox C; Graham J; Hollis J; Nasser E
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):241-6. PubMed ID: 14697444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
    Boström A; Lindman H; Swartling C; Berne B; Bergh J
    Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
    Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer.
    Pommier P; Gomez F; Sunyach MP; D'Hombres A; Carrie C; Montbarbon X
    J Clin Oncol; 2004 Apr; 22(8):1447-53. PubMed ID: 15084618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).
    Sio TT; Atherton PJ; Birckhead BJ; Schwartz DJ; Sloan JA; Seisler DK; Martenson JA; Loprinzi CL; Griffin PC; Morton RF; Anders JC; Stoffel TJ; Haselow RE; Mowat RB; Wittich MA; Bearden JD; Miller RC
    Support Care Cancer; 2016 Sep; 24(9):3847-55. PubMed ID: 27075674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind trial on the use of 1% hydrocortisone cream for the prevention of acute radiation dermatitis.
    Meghrajani CF; Co HS; Arcillas JG; Maaño CC; Cupino NA
    Expert Rev Clin Pharmacol; 2016; 9(3):483-91. PubMed ID: 26619355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial.
    Hindley A; Zain Z; Wood L; Whitehead A; Sanneh A; Barber D; Hornsby R
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):748-55. PubMed ID: 25585779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing cost per use of 3M Cavilon No Sting Barrier Film with zinc oxide oil in incontinent patients.
    Baatenburg de Jong H; Admiraal H
    J Wound Care; 2004 Oct; 13(9):398-400. PubMed ID: 15517755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
    Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
    Kong M; Hong SE
    Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study.
    Schmuth M; Wimmer MA; Hofer S; Sztankay A; Weinlich G; Linder DM; Elias PM; Fritsch PO; Fritsch E
    Br J Dermatol; 2002 Jun; 146(6):983-91. PubMed ID: 12072066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
    Ulff E; Maroti M; Serup J; Falkmer U
    Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial.
    Fenig E; Brenner B; Katz A; Sulkes J; Lapidot M; Schachter J; Malik H; Sulkes A; Gutman H
    Oncol Rep; 2001; 8(2):305-9. PubMed ID: 11182045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
    Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
    G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).
    Neben-Wittich MA; Atherton PJ; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Loprinzi CL; Burger KN; Martenson JA; Miller RC
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):397-402. PubMed ID: 20888137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study of radiotherapy-induced skin reactions in breast cancer patients: reduced incidence of moist desquamation with a hydroactive colloid gel versus dexpanthenol.
    Censabella S; Claes S; Orlandini M; Braekers R; Thijs H; Bulens P
    Eur J Oncol Nurs; 2014 Oct; 18(5):499-504. PubMed ID: 24877859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical agents for radiation dermatitis in breast cancer: 50 shades of red or same old, same old?
    Freedman GM
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):736-8. PubMed ID: 25585778
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of acute radiodermatitis with an oil-in-water emulsion following radiation therapy for breast cancer: a controlled, randomized trial.
    Jensen JM; Gau T; Schultze J; Lemmnitz G; Fölster-Holst R; May T; Abels C; Proksch E
    Strahlenther Onkol; 2011 Jun; 187(6):378-84. PubMed ID: 21603988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer: a phase 3, double-blind, randomized, controlled trial.
    Chan RJ; Mann J; Tripcony L; Keller J; Cheuk R; Blades R; Keogh S; Poole C; Walsh C
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):756-64. PubMed ID: 25151541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.